Granted Patent
Utility
US 6,518,416 · App. 09/796,491
Method of determining a chemotherapeutic regimen based on ERCC1 expression
Inventor:
Kathleen Danenberg
Patented Case
View Patent ↗
Granted: Feb 11, 2003
Filed: Mar 2, 2001
Inventor
Kathleen Danenberg
Assignee (at issue)
Response Genetics, Inc.
This patent predates the USPTO's electronic file wrapper — prosecution documents from this era exist only in the Patent Office's paper records. A certified copy of the file history can be ordered from the USPTO's paper archives.